TRACKING SYMPTOMS DURING CHEMOTHERAPY VIA ONLINE PATIENT SELF-REPORTING
Basch Ethan, Assistant Attending
Sloan-kettering Institute For Cancer Rescity: New York country: United States (us)
Grant 5K07CA124851-03 from National Cancer Institute
Abstract: This proposal envisions a comprehensive plan for the career development of Dr. Ethan Basch in cancer outcomes research. Through mentored research, coursework, and independent study, Dr. Basch will develop collaborative relationships and methodologic skills to support his research agenda in clinical informatics and patient symptom management. This work focuses on the use of novel technologies to improve symptom monitoring during cancer care and trials, specifically through the evaluation of patient- centered treatment models which integrate patient reported outcomes (PROs). Currently, it is not standard to use patients´ own self-reported symptom information to monitor cancer care. Rather, clinicians are relied upon to elicit, filter and report this information - an approach which is mandated in NCI and industry-sponsored trials. This stands in contrast to quality of life or symptom research, in which PROs are standard. The overall objective of this research program is to explore the application of patient self-reporting to symptom monitoring in oncology treatment, as a possible new paradigm. The specific aims are 1) to assess the feasibility of routinely collecting symptom PROs via the web during cancer care and trials; 2) to measure the relationship between patient and clinician symptom reporting using the standard U.S. instrument for this purpose, the NCI´s Common Terminology Criteria for Adverse Events (CTCAE); and 3) to evaluate the impact of patient self-reporting on clinical and administrative outcomes. This agenda will be accomplished through a series of IRB-approved studies Dr. Basch has designed and is systematically conducting at Memorial Sloan-Kettering Cancer Center, as well as nested in multicenter NCI and industry-sponsored clinical trials. RELEVANCE Patient self-reporting may increase the efficiency of clinical operations, foster early detection of serious adverse events, and improve patient satisfaction. Engaging patients as active participants in research and in their own care conveys the message that treatment tolerance is an important endpoint. This work will help determine how new technologies may be deployed to improve traditional models of care
Keywords: Accounting; Address; Administrative Efficiency; Adverse event; Adverse Experience; anticancer therapy; Area; Au element; Award; base; Behavior; Behavior Conditioning Therapy; behavior intervention; Behavior Modification; Behavior or Life Style Modifications; Behavior Therapy; Behavior Treatment; Behavioral Conditioning Therapy; behavioral intervention; Behavioral Modification; Behavioral Therapy; Behavioral Treatment; cancer care; Cancer Center; Cancer Patient; cancer therapy; Cancer Treatment; Cancer, Oncology; Cancers; career; career development; Career Development Awards; Career Development Awards and Programs; Career Development Programs K-Series; Caring; chemotherapy; Client satisfaction; Clinical; Clinical Informatics; clinical investigation; Clinical Research; Clinical Study; Clinical Trials; Clinical Trials, Unspecified; Common Terminology Criteria for Adverse Events; Common Toxicity Criteria; Communication; Conditioning Therapy; CTCAE; Data; Data Collection; Data Quality; design; designing; Detection; Documentation; Drug toxicity; early detection; Early Diagnosis; Electronics; Ensure; Ethics Committees, Research; Evaluation; experience; Exposure to; Feasibility Studies; Fostering; Funding; Goals; Gold; Health Care Research; health care service; health related quality of life; Health Services; Health Services Evaluation; Health Services Research; Healthcare Research; improved; Industry; Institutional Review Boards; instrument; Internet; Investigators; IRBs; K-Awards; K-Series Research Career Programs; Life; Life Style Modification; malignancy; Malignant Neoplasm Therapy; Malignant Neoplasm Treatment; Malignant Neoplasms; Malignant Tumor; Measures; Medical Care Research; Medical Oncology; Memorial Sloan-Kettering Cancer Center; Mentors; Methods; Minority; Modeling; Monitor; MSKCC; neoplasm/cancer; new technology; oncology; operation; Outcome; Outcomes Assessments, Patient; Outcomes Research; Participant; patient centered; patient oriented; Patient Outcomes Assessments; Patient Reported Outcomes; patient safety; Patient Satisfaction; Patient Self-Report; Patients; Process; programs; Programs (PT); Programs [Publication Type]; QOL; Quality of life; Questionnaires; randomized trial; Reporting; Research; Research Career Program; Research Career Programs, K-Series; Research Ethics Committees; Research Personnel; Research Support; Researchers; response; routine care; SAE; screening; Screening procedure; screenings; Self-Report; Series; Serious Adverse Event; services research; skills; symptom management; Symptoms; Testing; Time; tool; Toxic effect; Toxicities; Treatment outcome; treatment trial; web; Work; world wide web; WWW
Project start date: 2008-03-28
Project end date: 2013-02-28
Budget start date: 1-MAR-2010
Budget end date: 28-FEB-2011
PFA/PA: PAR-06-381
5K07CA124851-03 (2010): $133978
Sponsored Links Excellgen http://Excellgen.com
TRACKING SYMPTOMS DURING CHEMOTHERAPY VIA ONLINE PATIENT SELF-REPORTING
Basch Ethan, Assistant Attending
Sloan-kettering Institute For Cancer Rescity: New York country: United States (us)
Grant 5K07CA124851-04 from National Cancer Institute
Abstract: This proposal envisions a comprehensive plan for the career development of Dr. Ethan Basch in cancer outcomes research. Through mentored research, coursework, and independent study, Dr. Basch will develop collaborative relationships and methodologic skills to support his research agenda in clinical informatics and patient symptom management. This work focuses on the use of novel technologies to improve symptom monitoring during cancer care and trials, specifically through the evaluation of patient- centered treatment models which integrate patient reported outcomes (PROs). Currently, it is not standard to use patients´ own self-reported symptom information to monitor cancer care. Rather, clinicians are relied upon to elicit, filter and report this information - an approach which is mandated in NCI and industry-sponsored trials. This stands in contrast to quality of life or symptom research, in which PROs are standard. The overall objective of this research program is to explore the application of patient self-reporting to symptom monitoring in oncology treatment, as a possible new paradigm. The specific aims are 1) to assess the feasibility of routinely collecting symptom PROs via the web during cancer care and trials; 2) to measure the relationship between patient and clinician symptom reporting using the standard U.S. instrument for this purpose, the NCI´s Common Terminology Criteria for Adverse Events (CTCAE); and 3) to evaluate the impact of patient self-reporting on clinical and administrative outcomes. This agenda will be accomplished through a series of IRB-approved studies Dr. Basch has designed and is systematically conducting at Memorial Sloan-Kettering Cancer Center, as well as nested in multicenter NCI and industry-sponsored clinical trials. RELEVANCE Patient self-reporting may increase the efficiency of clinical operations, foster early detection of serious adverse events, and improve patient satisfaction. Engaging patients as active participants in research and in their own care conveys the message that treatment tolerance is an important endpoint. This work will help determine how new technologies may be deployed to improve traditional models of care
Keywords: Accounting; Address; Administrative Efficiency; Adverse event; Adverse Experience; anticancer therapy; Area; Au element; Award; base; Behavior; Behavior Conditioning Therapy; behavior intervention; Behavior Modification; Behavior or Life Style Modifications; Behavior Therapy; Behavior Treatment; Behavioral Conditioning Therapy; behavioral intervention; Behavioral Modification; Behavioral Therapy; Behavioral Treatment; cancer care; Cancer Center; Cancer Patient; cancer therapy; Cancer Treatment; Cancer, Oncology; Cancers; career; career development; Career Development Awards; Career Development Awards and Programs; Career Development Programs K-Series; Caring; chemotherapy; Client satisfaction; Clinical; Clinical Informatics; clinical investigation; Clinical Research; Clinical Study; Clinical Trials; Clinical Trials, Unspecified; Common Terminology Criteria for Adverse Events; Common Toxicity Criteria; Communication; Conditioning Therapy; CTCAE; Data; Data Collection; Data Quality; design; designing; Detection; Documentation; Drug toxicity; early detection; Early Diagnosis; Electronics; Ensure; Ethics Committees, Research; Evaluation; experience; Exposure to; Feasibility Studies; Fostering; Funding; Goals; Gold; Health Care Research; health care service; health related quality of life; Health Services; Health Services Evaluation; Health Services Research; Healthcare Research; improved; Industry; Institutional Review Boards; instrument; Internet; Investigators; IRBs; K-Awards; K-Series Research Career Programs; Life Style Modification; malignancy; Malignant Neoplasm Therapy; Malignant Neoplasm Treatment; Malignant Neoplasms; Malignant Tumor; Measures; Medical Care Research; Medical Oncology; Memorial Sloan-Kettering Cancer Center; Mentors; Methods; Minority; Modeling; Monitor; MSKCC; neoplasm/cancer; new technology; oncology; operation; Outcome; Outcomes Assessments, Patient; Outcomes Research; Participant; patient centered; patient oriented; Patient Outcomes Assessments; Patient Reported Outcomes; patient safety; Patient Satisfaction; Patient Self-Report; Patients; Process; programs; Programs (PT); Programs [Publication Type]; QOL; Quality of life; Questionnaires; randomized trial; Reporting; Research; Research Career Program; Research Career Programs, K-Series; Research Ethics Committees; Research Personnel; Research Support; Researchers; response; routine care; SAE; screening; Screening procedure; screenings; Self-Report; Series; Serious Adverse Event; services research; skills; symptom management; Symptoms; Testing; Time; tool; Toxic effect; Toxicities; Treatment outcome; treatment trial; web; Work; world wide web; WWW
Project start date: 2008-03-28
Project end date: 2013-02-28
Budget start date: 1-MAR-2011
Budget end date: 29-FEB-2012
PFA/PA: PAR-06-381
5K07CA124851-04 (2011): $133978